NATIXIS ADVISORS, LLC - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 210 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIXIS ADVISORS, LLC ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$2,843,000
-26.7%
71,549
+27.4%
0.05%
-25.8%
Q2 2015$3,879,000
+26.7%
56,169
+0.3%
0.07%
+22.2%
Q1 2015$3,061,000
+26.5%
56,003
-1.3%
0.05%
+20.0%
Q4 2014$2,419,00056,7490.04%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
HealthInvest Partners AB 740,585$17,330,0008.11%
Palo Alto Investors LP 2,906,194$68,005,0005.28%
Opaleye Management Inc. 220,000$5,148,0003.21%
Endurant Capital Management LP 265,180$6,205,0002.01%
FALCON POINT CAPITAL, LLC 381,081$8,917,0001.54%
STELLIAM INVESTMENT MANAGEMENT, LP 1,470,000$34,398,0001.06%
AlphaOne Investment Services, LLC 91,824$2,149,0000.88%
ASHFORD CAPITAL MANAGEMENT INC 153,325$3,588,0000.85%
IRONWOOD INVESTMENT MANAGEMENT LLC 55,097$1,289,0000.84%
Camber Capital Management LP 600,000$14,040,0000.82%
View complete list of AMAG PHARMACEUTICALS INC shareholders